Women across the United States can now find out their risk of developing breast cancer in the near future with the help of an artificial intelligence tool that examines a single recent mammogram.

Everlywell, a digital health company, announced it will offer patients nationwide access to Clairity Breast, an AI tool, approved by the Food and Drug Administration last year, to predict a woman’s five-year risk of breast cancer based on imaging. The test, which was previously available only at select locations in Massachusetts and Colorado, will cost $249. It is not covered by insurance.

Doctors use mammograms to detect the presence of cancer, sometimes with the help of AI models that can read the images.…